Belgium vs Latvia: Cause of death, by non-communicable diseases, ages 15-59
Belgium
68.9%
in 2021
Latvia
70.1%
in 2021
Belgium rank
38th
Latvia rank
36th
Cause of death, by non-communicable diseases, ages 15-59 over time
- Belgium
- Latvia
How they compare
Latvia currently reports 70.1% against 68.9% in Belgium, a difference of 1.2%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Belgium ahead.
Belgium ranks 38th and Latvia ranks 36th of 185 countries.
Across the 3 decades both report, Belgium averaged higher in 2 and Latvia in 1.
Head to head by decade
| Decade | Belgium | Latvia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 71.3% | 62.6% | 8.7% | Belgium |
| 2010s | 73.6% | 73.4% | 0.2% | Belgium |
| 2020s | 68.0% | 72.7% | 4.8% | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, Belgium or Latvia?
- Latvia, at 70.1% against 68.9% in Belgium as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59 between Belgium and Latvia?
- 1.2%, with Latvia ahead.
- How many years of comparable data are there for Belgium and Latvia?
- 6 years are reported by both, from 2000 to 2021.
- How do Belgium and Latvia rank globally for cause of death, by non-communicable diseases, ages 15-59?
- Belgium ranks 38th and Latvia ranks 36th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59 (% of total deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 15-59 due to non-communicable diseases divided by number of all deaths ages 15-59 expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.